rhizochaline has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedorov, SN; Guzii, AG; Kwak, JY; Makarieva, TN; Shubina, LK; Stonik, VA | 1 |
1 other study(ies) available for rhizochaline and Leukemia
| Article | Year |
|---|---|
Marine two-headed sphingolipid-like compound rhizochalin inhibits EGF-induced transformation of JB6 P+ Cl41 cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Fatty Alcohols; Glycosides; Humans; Leukemia; Mice; Porifera; Tumor Suppressor Protein p53 | 2009 |